Elevance Health(ELV)
Search documents
Elevance Health(ELV) - 2021 Q2 - Earnings Call Transcript
2021-07-21 19:38
Anthem, Inc. (ANTM) Q2 2021 Earnings Conference Call July 21, 2021 8:30 AM ET Company Participants Stephen Tanal - Vice President of Investor Relations Gail Boudreaux - President and Chief Executive Officer John Gallina - Executive Vice President and Chief Financial Officer Felicia Norwood - Executive Vice President and President, Government Business Division Peter Haytaian - Executive Vice President and President, Commercial and Specialty Business Division Jeff Alter - Executive Vice President IngenioRx an ...
Elevance Health(ELV) - 2021 Q2 - Quarterly Report
2021-07-20 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-16751 ANTHEM, INC. (Exact name of registrant as specified in its charter) Indiana 35-2145715 (State or other jurisdiction of inc ...
Elevance Health(ELV) - 2021 Q1 - Earnings Call Transcript
2021-04-21 15:43
Anthem, Inc. (ANTM) Q1 2021 Earnings Conference Call April 21, 2021 8:30 AM ET Company Participants Steve Tanal - Vice President, Investor Relations Gail Boudreaux - President and Chief Executive Officer John Gallina - Chief Financial Officer Felicia Norwood - President, Government Business Division Pete Haytaian - President, Commercial and Specialty Business Division Conference Call Participants Justin Lake - Wolfe Research Matt Borsch - BMO Capital Markets A.J. Rice - Credit Suisse Lance Wilkes - Bernstei ...
Elevance Health(ELV) - 2021 Q1 - Quarterly Report
2021-04-20 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Title of each class Trading symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value ANTM New York Stock Exchange For the Quarterly Period Ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file ...
Elevance Health(ELV) - 2020 Q4 - Annual Report
2021-02-17 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-16751 ANTHEM, INC. (Exact name of registrant as specified in its charter) Indiana 35-2145715 (State or other jurisdiction of incorpo ...
Elevance Health(ELV) - 2020 Q4 - Earnings Call Transcript
2021-01-27 21:24
Anthem, Inc. (ANTM) Q4 2020 Earnings Conference Call January 27, 2021 8:30 AM ET Â Company Participants Chris Rigg – Vice President-Investor Relations Gail Boudreaux – President and Chief Executive Officer John Gallina – Chief Financial Officer Pete Haytaian – President-Commercial and Specialty Business Division Felicia Norwood – President-Government Business Division Conference Call Participants Justin Lake – Wolfe Research A.J. Rice – Credit Suisse Steven Valiquette – Barclays Ricky Goldwasser – Morgan St ...
Elevance Health(ELV) - 2020 Q3 - Quarterly Report
2020-10-28 20:02
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Title of each class Trading symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value ANTM New York Stock Exchange For the Quarterly Period Ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission f ...
Elevance Health(ELV) - 2020 Q3 - Earnings Call Transcript
2020-10-28 19:25
Anthem, Inc. (ANTM) Q3 2020 Earnings Conference Call October 28, 2020 8:30 AM ET Â Company Participants Chris Rigg - Vice President, Investor Relations Gail Boudreaux - President and Chief Executive Officer John Gallina - Chief Financial Officer Felicia Norwood - President of Government Business Division Pete Haytaian - President of Commercial and Specialty Business Division Conference Call Participants Stephen Valiquette - Barclays A.J. Rice - Credit Suisse Justin Lake - Wolfe Research Ricky Goldwasser - M ...
Elevance Health(ELV) - 2020 Q2 - Quarterly Report
2020-07-29 19:54
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) Title of each class Trading symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value ANTM New York Stock Exchange ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file n ...
Elevance Health(ELV) - 2020 Q2 - Earnings Call Transcript
2020-07-29 19:20
Anthem, Inc. (ANTM) Q2 2020 Earnings Conference Call July 29, 2020 8:30 AM ET Â Company Participants Chris Rigg - Vice President, Investor Relations Gail Boudreaux - President and Chief Executive Officer John Gallina - Chief Financial Officer Felicia Norwood - President of Government Business Division Pete Haytaian - President of Commercial and Specialty Business Division Conference Call Participants Ricky Goldwasser - Morgan Stanley Justin Lake - Wolf Research Stephen Tanal - SVB Leerink A.J. Rice - Credit ...